STOCK TITAN

Intercept to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq:ICPT) announced that Jerry Durso, President and CEO, and Sandip Kapadia, CFO, will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021, at 1:00 p.m. ET and at the Cowen 41st Annual Healthcare Conference on March 2, 2021, at 10:30 a.m. ET. A live webcast will be available on Intercept’s investor page, with an archive accessible for two weeks afterward. Intercept focuses on developing therapeutics for progressive non-viral liver diseases like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).

Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer, and Sandip Kapadia, Chief Financial Officer of Intercept, will present at the SVB Leerink 10th Annual Global Healthcare Conference on Friday, February 26, 2021 at 1:00 p.m. ET, and at the Cowen 41st Annual Healthcare Conference on Tuesday, March 2, 2021 at 10:30 a.m. ET.

A live webcast of the events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:     

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com


FAQ

When will Intercept Pharmaceuticals present at the SVB Leerink Global Healthcare Conference 2021?

Intercept Pharmaceuticals will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021, at 1:00 p.m. ET.

What time will Intercept Pharmaceuticals present at the Cowen Healthcare Conference 2021?

Intercept Pharmaceuticals will present at the Cowen 41st Annual Healthcare Conference on March 2, 2021, at 10:30 a.m. ET.

How can I watch the Intercept Pharmaceuticals conference presentations?

The presentations can be streamed live via the investor page of Intercept Pharmaceuticals' website.

What is Intercept Pharmaceuticals' focus in drug development?

Intercept Pharmaceuticals focuses on developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown